Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Conley

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
JCO Clinical Cancer Informatics|January 18, 2019
High-Throughput Architecture for Discovering Combination Cancer TherapeuticsMatt Gianni, Yong Qin, Geert Wenes, et al.
Current Oncology Reports|March 28, 2018
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven BiologyMarc El Beaino, Jason Roszik, John A Livingston, et al.
Cardiovascular and Interventional Radiology|June 16, 2012
Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcomaJeremiah L Deneve, Junsung Choi, Ricardo J Gonzalez, et al.
Molecular Oncology|December 1, 2010
Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cellsDavid Reynoso, Laura K Nolden, Dan Yang, et al.
The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.
Neurosurgery|September 14, 2019
Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of RelapseShaan M Raza, Ahmed Habib, Wei-Lien Wang, et al.
The Canadian Journal of Cardiology|August 21, 2017
Progressive and Reversible Conduction Disease With Checkpoint InhibitorsNeeti Reddy, Rohit Moudgil, Juan C Lopez-Mattei, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptorJocelyn Joseph, Michael J Nathenson, Van Anh Trinh, et al.
Cancer|July 10, 2024
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordomaGregory M Cote, Anthony P Conley, Steven Attia, et al.
Clinical Sarcoma Research|April 2, 2020
The immune microenvironment of uterine adenosarcomasAli Mohammed Refaat Ali, Jen-Wei Tsai, Cheuk Hong Leung, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
JCO Clinical Cancer Informatics|January 18, 2019
High-Throughput Architecture for Discovering Combination Cancer TherapeuticsMatt Gianni, Yong Qin, Geert Wenes, et al.
Current Oncology Reports|March 28, 2018
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven BiologyMarc El Beaino, Jason Roszik, John A Livingston, et al.
Cardiovascular and Interventional Radiology|June 16, 2012
Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcomaJeremiah L Deneve, Junsung Choi, Ricardo J Gonzalez, et al.
Molecular Oncology|December 1, 2010
Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cellsDavid Reynoso, Laura K Nolden, Dan Yang, et al.
The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.
Neurosurgery|September 14, 2019
Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of RelapseShaan M Raza, Ahmed Habib, Wei-Lien Wang, et al.
The Canadian Journal of Cardiology|August 21, 2017
Progressive and Reversible Conduction Disease With Checkpoint InhibitorsNeeti Reddy, Rohit Moudgil, Juan C Lopez-Mattei, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptorJocelyn Joseph, Michael J Nathenson, Van Anh Trinh, et al.
Cancer|July 10, 2024
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordomaGregory M Cote, Anthony P Conley, Steven Attia, et al.
Clinical Sarcoma Research|April 2, 2020
The immune microenvironment of uterine adenosarcomasAli Mohammed Refaat Ali, Jen-Wei Tsai, Cheuk Hong Leung, et al.
Pageof 8